Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Formestane |
Aromatase Inhibitor | Solid Tumour (Breast) | ||
|
Molecule
Formestane
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
||||
Forodesine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Forodesine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Fosaprepitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Fosaprepitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Foscarnet Sodium |
Antiviral / Antiprotozoal Prophylaxis | Both (Solid & Hematologic) | ||
|
Molecule
Foscarnet Sodium
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antiviral / Antiprotozoal Prophylaxis |
||||
Fosfestrol |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Fosfestrol
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Fosnetupitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Fosnetupitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Fotemustine |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Fotemustine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Fulvestrant |
Selective Estrogen Receptor Degrader (SERD) | Solid Tumour (Breast) | ||
|
Molecule
Fulvestrant
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
||||
Gabapentin (Onc Neuropathic Pain) |
Opioid / Adjuvant Analgesic | Both (Solid & Hematologic) | ||
|
Molecule
Gabapentin (Onc Neuropathic Pain)
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
||||
Galarubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Galarubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Galeterone |
CYP17 / Androgen Synthesis Inhibitor | Solid Tumour (Prostate) | ||
|
Molecule
Galeterone
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
||||
Ganciclovir |
Antiviral / Antiprotozoal Prophylaxis | Both (Solid & Hematologic) | ||
|
Molecule
Ganciclovir
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antiviral / Antiprotozoal Prophylaxis |
||||
FormestaneHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
|
ForodesineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
FosaprepitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
Foscarnet SodiumSupportive Care (Anti-Infective) |
|
|
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antiviral / Antiprotozoal Prophylaxis |
|
FosfestrolHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
FosnetupitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
FotemustineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
FulvestrantHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
|
Gabapentin (Onc Neuropathic Pain)Supportive Care (Analgesic) |
|
|
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
|
GalarubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
GaleteroneHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
|
GanciclovirSupportive Care (Anti-Infective) |
|
|
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antiviral / Antiprotozoal Prophylaxis |
|